Literature DB >> 15889005

Summary of notifiable diseases--United States, 2003.

Richard S Hopkins1, Ruth Ann Jajosky, Patsy A Hall, Deborah A Adams, Felicia J Connor, Pearl Sharp, Willie J Anderson, Robert F Fagan, J Javier Aponte, David A Nitschke, Carol A Worsham, Nelson Adekoya, Man-huei Chang.   

Abstract

The Summary of Notifiable Diseases--United States, 2003 contains the official statistics, in tabular and graphic form, for the reported occurrence of nationally notifiable diseases in the United States for 2003. Unless otherwise noted, the data are final totals for 2003 reported as of June 30, 2004. These statistics are collected and compiled from reports sent by state health departments to the National Notifiable Diseases Surveillance System (NNDSS), which is operated by CDC in collaboration with the Council of State and Territorial Epidemiologists (CSTE). The Summary is available at http://www.cdc.gov/mmwr/summary.html. This site also includes publications from past years.

Mesh:

Year:  2005        PMID: 15889005

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  31 in total

Review 1.  Chronic Q fever in the United States.

Authors:  Petros C Karakousis; Michele Trucksis; J Stephen Dumler
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Behavioral and attitudes survey about Lyme disease among a Brazilian population in the endemic area of Martha's Vineyard, Massachusetts.

Authors:  Jenny E Heller; Elizabeth Benito-Garcia; Nancy E Maher; Lori B Chibnik; Colin P Maher; Nancy A Shadick
Journal:  J Immigr Minor Health       Date:  2008-09-16

3.  Rubella Surveillance and Diagnostic Testing among a Low-Prevalence Population, New York City, 2012-2013.

Authors:  Beth M Isaac; Jane R Zucker; Francesca R Giancotti; Emily Abernathy; Joseph Icenogle; Jennifer L Rakeman; Jennifer B Rosen
Journal:  Clin Vaccine Immunol       Date:  2017-09-05

4.  Assessing the impact of a pertussis active surveillance program on provider testing behavior, Minnesota 2005-2009.

Authors:  Cynthia Kenyon; Emily Banerjee; Kristin Sweet; Claudia Miller; Kristen Ehresmann
Journal:  Am J Public Health       Date:  2014-02-13       Impact factor: 9.308

5.  Increased risk of pertussis in patients with asthma.

Authors:  Conrad R Capili; Allison Hettinger; Natalie Rigelman-Hedberg; Lisa Fink; Thomas Boyce; Brian Lahr; Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

6.  Multivalent recombinant protein vaccine against coccidioidomycosis.

Authors:  Eric J Tarcha; Venkatesha Basrur; Chiung-Yu Hung; Malcolm J Gardner; Garry T Cole
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

7.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

8.  Lyme disease in Oregon.

Authors:  J Stone Doggett; Sue Kohlhepp; Robert Gresbrink; Paul Metz; Curt Gleaves; David Gilbert
Journal:  J Clin Microbiol       Date:  2008-04-30       Impact factor: 5.948

9.  Immune responses to mumps vaccine in adults who were vaccinated in childhood.

Authors:  Rima Hanna-Wakim; Linda L Yasukawa; Phillip Sung; Ann M Arvin; Hayley A Gans
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 5.226

Review 10.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.